This year's review of enucleation, evisceration, and sympathetic ophthalmia yielded a multitude of studies and data. Articles ranged from single case reports to large clinical series and in-depth subject overviews. With regard to enucleation, several new HA implant variations were described, along with limited clinical experience. Various techniques for management of postenucleation and evisceration complications also were described, including management of infection, implant exposure, and postenucleation socket syndrome. The risk of sympathetic ophthalmia after evisceration, as compared with enucleation, remains a highly polarized and inconclusive subject.